Credential Securities’s Novartis NVS Stock Holding History

Credential Securities’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$332K	Sell	4,908 -303	-6%	-$20.9K	0.08%	135
2018 Q1	$377K	Sell	5,211 -48	-0.9%	-$3.65K	0.09%	137
2017 Q4	$396K	Buy	5,259 +26	+0.5%	+$1.96K	0.1%	137
2017 Q3	$403K	Buy	5,233 +1,836	+54%	+$139K	0.11%	135
2017 Q2	$256K	Sell	3,397 -107	-3%	-$7.58K	0.08%	155
2017 Q1	$233K	Sell	3,504 -14	-0.4%	-$933	0.08%	160
2016 Q4	$230K	Sell	3,518 -1,493	-30%	-$96.8K	0.09%	155
2016 Q3	$354K	Buy	5,011 +1,715	+52%	+$125K	0.16%	135
2016 Q2	$244K	Sell	3,296 -877	-21%	-$60.6K	0.13%	147
2016 Q1	$271K	Sell	4,173 -5,251	-56%	-$357K	0.16%	140
2015 Q4	$726K	Buy	9,424 +271	+3%	+$21.5K	0.48%	69
2015 Q3	$754K	Buy	9,153 +88	+1%	+$7.83K	0.52%	61
2015 Q2	$799K	Buy	9,065 +271	+3%	+$24.9K	0.5%	59
2015 Q1	$777K	Buy	8,794 +480	+6%	+$42.6K	0.5%	58
2014 Q4	$690K	Buy	8,314 +1,857	+29%	+$154K	0.45%	70
2014 Q3	$541K	Buy	6,457 +352	+6%	+$28.5K	0.36%	81
2014 Q2	$495K	Buy	6,105 +564	+10%	+$44.4K	0.33%	89
2014 Q1	$422K	Buy	+5,541	New	+$404K	0.32%	92

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Credential Securities's NVS Position: Q2 2018 in Review

Credential Securities reduced its Novartis (NVS) stake by 5.8% in Q2 2018, selling an estimated $20.9K and leaving 4,908 shares worth $332K. The position accounts for 0.08% of the portfolio, ranked #135.

Credential Securities first reported a position in NVS in Q1 2014 and has held it in 18 quarters since. The position peaked at $799K in Q2 2015. 988 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

Credential Securities held 4,908 shares of Novartis worth $332K as of Q2 2018.
Credential Securities sold 303 Novartis shares in Q2 2018, an estimated $20.9K.
Novartis made up 0.08% of Credential Securities's portfolio in Q2 2018, its #135 holding.
Credential Securities first reported a position in Novartis in Q1 2014 and has held it in 18 quarters since.
Credential Securities's Novartis position peaked at $799K in Q2 2015.
988 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.